European ecigarette e-liquids — buy online — elusion electronic cigarette — buy electronic cigarettes online

Introducing our new range of European sourced E Liquids

Select between 5 10 European e liquids get 40% off
Select between 11 15 European e liquids get 50% off
Select 16 European e liquids get a massive 60% off

You can mix and match any of our European e liquid range to achieve BIG savings.

Elusion&trade is committed to sourcing and supplying the finest quality products on the E Cigarette market, and we understand that some people enjoy the taste of a traditional cigarette as opposed to alternative flavours such as fruit or menthol.

Our range of European E Liquids offer a superior taste sensation through a careful blending process to substantially replicate the taste of six of the World s leading cigarette brands providing an improved E Cigarette experience.

Simply choose your E Liquid colour by matching it to your preferred traditional cigarette brand

  • Elusion&trade Silver Winfield
  • Elusion&trade Gold Benson & Hedges
  • Elusion&trade Red Marlboro
  • Elusion&trade Blue Dunhill
  • Elusion&trade Green Parliament
  • Elusion&trade White Davidoff

These trade marks belong to the respective owners of these brands.

WINFIELD British American Tobacco Australasia Ltd. BENSON & HEDGES and PARLIAMENT The Benson & Hedges Co Pty Philip Morris Products Inc. DUNHILL Dunhill Tobacco of London Ltd. DAVIDOFF Davidoff & Cie SA. Elusion is not associated with or connected with these brands or these companies. These trade marks are used for comparison purposes. The respective Elusion E Liquid in our opinion an approximation of the flavour of the respective brand. The experience obtained from inhaling the vaporised E Liquid will not exactly replicate the experience of smoking a real cigarette

[epha briefing] regulation of nicotine containing products (ncps) including electronic cigarettes — european public health alliance

The future legislation of Nicotine containing products (NCPs) including e cigarettes is part of ongoing discussion on the revision of Tobacco Products Directive (TPD).

EPHA Briefing on Regulatory options for Nicotine Containing Products (NCPs) in the EU

Annexes to the EPHA Briefing on Regulatory options for Nicotine Containing Products (NCPs) in the EU

In light of the available regulatory options for Nicotine Containing Products (NCPs), identified and presented in the EPHA Briefing, EPHA recommends the following principles of future EU wide NCP legislation, public health requirements of NCPs, and policy options for regulating NCPs

Principles of future EU wide NCP legislation

  • Public health needs to be the driving motivation of regulation of NCPs. All NCPs should demonstrate proven safety and quality
  • NCPs must not become a gateway product, especially for young people and must not re normalise smoking
  • NCPs should be regulated at EU level, in order to reduce existing health inequalities, and to provide greater legal certainty, in line with the EPHA European Charter for Health Equity
  • NCPs should be regulated in an appropriate manner in line with the precautionary principle.
  • Future NCP regulation should take into consideration the future and fast development of this market.
  • NCPs should facilitate access to social support networks through the provision of information. Tobacco cessation services (quit lines) are crucial to sustained and successful efforts to quit smoking. NCPs of high quality have significant potential to help smokers who are not otherwise ready or able to quit smoking.

Public Health requirements of NCPs

Regulation of NCPs, including e cigarettes, needs to protect public health by ensuring

  • product safety and quality,
  • control of advertising and sponsorship,
  • market surveillance and monitoring,
  • accesibility of NCPs for existing smokers

Policy options for regulating NCPs

  • Appropriate safety assessment should be a cornerstone of any future EU legislation.
  • The public health benefit of NCPs is that they may help smokers to quit smoking. In order to maintain the same standards for the same products, both the product safety aspects and the claimed effects of the given product should be taken into consideration by future regulation of NCPs.
  • Strict marketing limits similar to tobacco and medicine marketing rules are essential so that NCPs do not promote smoking behaviour either in a direct or indirect way.
  • Given the potential of products such as e cigarettes not containing nicotine to indirectly promote smoking and undermine smoking cessation policy, the European Commission should be empowered to adopt delegated acts to regulate these products appropriately.
  • Having no new regulation on NCPs, or maintaining long transitional periods which is equivalent to maintaining the status quo has the potential danger of market developments which do not provide a high level of public health protection to EU citizens, violating Article 168 of the Treaty on the Functioning of the European Union (TFEU). Therefore, the transition period before the application of the new NCP legislation, as well as the binding deadline for the European Commission to submit a report about the application of the future NCP legislation should be as short as possible, and the European Commission should be empowered to adopt delegated acts in other to be able to reflect public health risks emerging from the rapid market development.
  • Appropriate monitoring including surveys and data collection is necessary so that any future legislation should rely on the latest data and evidence. Particular attention should be given to the attitudes and preferences of children and young people in that regard.
  • Future regulations should include elements which ensure appropriate funding and resources for more research for both social and biomedical aspects of NCPs.
  • Flavourings have two dimensions On the one hand, some flavours are necessary to make NCPs intended for oral use palatable. On the other hand, additional flavours can make NCPs more attractive for both smokers and non smokers. NCPs should be allowed to contain the necessary flavours which are allowed in Nicotine Replacement Therapies (NRT) but should be subject to flavouring restrictions, as regards additional flavourings not necessary for the use.
  • An appropriate simplified authorisation procedure for NCPs merging the necessary elements of other legislations would be useful ensuring that NCPs comply with the principles and guidelines of Good Manufacturing Practice (GMP), Manufacturers present all ingredients of the products, including emissions and a Risk Management Plan for monitoring and recording any adverse reactions, similarly, NCPs should be subject to appropriate labelling and packaging rules
  • The future legal framework should ensure that accessibility to NCPs for existing smokers is not hindered while ensuring that they are unappealing and inaccessible to minors.

EPHA related articles

  • Joint press statement Mixed victory for tobacco control in European Parliament’s vote
  • Final countdown public health community calls on European Parliament to vote for a strong Tobacco Products Directive
  • Joint Open Letter to President of European Parliament Philip Morris lobbying activities on the Tobacco Products Directive
  • EPHA Calls for Strong Tobacco Products Directive (TPD) without further delay
  • Sign the ERS petition for a strong Tobacco Products Directive!
  • Global Initiative Don’t Touch the Spanish Tobacco Law
  • EPHA Open Letter to Spanish Prime Minister Smoking should be banned at «Eurovegas»
  • EPHA and Public Health NGOs call for an updated EU Tobacco Products Directive
  • EPHA position paper Revision of the Tobacco Products Directive
  • EPT Tobacco Directive (Revision) European Commission Proposal Revision of The Tobacco Products Directive (25 June 2013)